Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
CDRE · NYSE · United States · Orthopedic, Prosthetic & Surgical Appliances & Supplies
In shortCadre Holdings, Inc. is profitable, generates cash and carries moderate debt, with revenue growing (+7.5% last year).
Financial health
Strong
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 11.0% | 53/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 7.2% | 49/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 14.0% | 70/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 7.6% | 51/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 3.50× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.97× | 57/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 2.14× | 53/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 3.70 | 67/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 9.3% | 57/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.29× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 5 | 100/100 |
| Revenue growth volatility | 5.1% | 92/100 |
| Operating margin volatility | 3.6% | 76/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 10.1% | 73/100 |
|---|---|---|
| EPS growth, 3-year average | 85.4% | 100/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
1 older year available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 427 | 458 | 483 | 568 | 610 |
| Cost of revenue | 257 | 282 | 282 | 334 | 351 |
| Gross profit | 171 | 176 | 201 | 233 | 260 |
| Research & development | 6.5 | 7.1 | 7 | 8.4 | 11 |
| Selling, general & admin | 115 | 153 | 141 | 158 | 183 |
| Operating income | 52 | 17 | 57 | 67 | 67 |
| Interest expense | 16 | 6.2 | 4.5 | 7.8 | – |
| Pre-tax income | 19 | 9.4 | 53 | 54 | 62 |
| Income tax | 6.5 | 3.6 | 14 | 18 | 18 |
| Net income | 13 | 5.8 | 39 | 36 | 44 |
| Diluted EPS | $0.44 | $0.16 | $1.02 | $0.90 | $1.02 |
| Diluted shares (millions) | 29 | 36 | 38 | 40 | 43 |
1 older year available with the 10-year history. Essential plan, from €8.25/month →
3.70 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 5, 2026